Evidence mapPaperPMID 41328549Full record

ArticleDiabetes, obesity & metabolism2026

Severity of complications is associated with impaired health-related quality of life in people with type 1 diabetes.

Sara Barraud, Gloria A Aguayo, Emmanuel Cosson, Chloé Amouyal, Sylvie Feldman, Jean-François Gautier, Patricia Vaduva, Samy Hadjadj, Hélène Hanaire, Laurence Kessler and 11 more

Abstract read
In one paragraph

Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Sara BarraudCRESTIC, Service d'Endocrinologie Diabète Nutrition, URCA, CHU de Reims, Reims, France.ORCID 0000-0001-6987-9218
Gloria A AguayoDeep Digital Phenotyping Research Unit, Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg.
Emmanuel CossonService d'Endocrinologie-Diabétologie-Nutrition, AP-HP, Avicenne Hospital, Paris 13 University, CRNH-IdF, CINFO, Université Sorbonne Paris Nord, Bobigny, France.
Chloé AmouyalDepartment of Diabetology, Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière University, Nutrition and Obesities: Systemic Approaches, NutriOmics, Research Unit, Sorbonne Université, Paris, France.
Sylvie FeldmanCentre d'Investigation Clinique 1423, INSERM, Hôpital de la vision des 15-20, Paris, France.
Jean-François GautierService de Diabètes et Endocrinologie APHP, INSERM U1138, Hôpital Lariboisière, Paris, France.
Patricia VaduvaService d'Endocrinologie-Diabétologie-Nutrition, Centre Hospitalier Universitaire de Rennes, Hôpital Sud, Rennes, France.
Samy HadjadjInstitut du thorax, INSERM, CNRS, UNIV Nantes, CHU Nantes, Nantes, France.
Hélène HanaireDepartment of Diabetology, Metabolic Diseases and Nutrition, CHU Toulouse, University of Toulouse, Toulouse, France.ORCID 0000-0002-8794-8990
Laurence KesslerService d'endocrinologie, diabète et nutrition, CHRU Strasbourg, Strasbourg, France.
Emmanuelle Lecornet-SokolIPE, Paris, France.
Pascale MassinCentre d'Ophtalmologie Paris Breteuil, Paris, France.
Louis PotierINSERM U1151, CNRS UMR 8253, IMMEDIAB Laboratory, Institut Necker-Enfants Malades, Paris, France.
Eric RenardDepartment of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, Montpellier, France.ORCID 0000-0002-3407-7263
Yves ReznikEndocrinology and Diabetes Department, CHU Côte de Nacre, Caen, France.ORCID 0000-0002-6267-8058
Agnès SolaDiabetology Department, Cochin Hospital, AP-HP, Paris, France.
Anne VambergueEndocrinology, Diabetology, Metabolism and Nutrition Department, Lille University Hospital, Lille, France.ORCID 0000-0003-4307-8695
Camille VatierService d'Endocrinologie, Centre de Référence des Maladies Rares de l'Insulino-Sécrétion et de l'Insulino-Sensibilité (PRISIS), Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.
Bruno VergèsDepartment of Endocrinology-Diabetology, Inserm LNC UMR1231, University of Burgundy, Dijon, France.
Jean-Pierre RivelineService de Diabètes et Endocrinologie, Hôpital Lariboisière, APHP, Paris, France.
Guy FagherazziDeep Digital Phenotyping Research Unit, Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg.ORCID 0000-0001-5033-5966

Funding

AbbottAide aux Jeunes DiabétiquesAir Liquide HealthcareBreakthrough T1DDexcomEli Lilly and CompanyFédération Française des DiabétiquesFoundation Francophone pour la Recherche sur le DiabèteInsulet CorporationLifescanLuxembourg Institute of HealthMedtronic EuropeNovo NordiskSanofiSociété Francophone du DiabèteSur les Pas de SoYpsomed
6 · The paper itself

Abstract

aimsHealth-related quality of life (HRQoL) assessment is increasingly integrated into type 1 diabetes (T1D) monitoring to promote a holistic approach. To investigate HRQoL in adults with T1D and to assess the impact of the severity of complications on HRQoL. MATERIALS AND

methodsThis is a cross-sectional analysis of baseline characteristics of adults living with T1D included in Société Francophone du Diabète - Cohorte Diabète de Type 1 (SFDT1), a French longitudinal cohort study. HRQoL was assessed using generic (EuroQol 5-Dimensions 5-Level questionnaire [EQ-5D-5L]) and diabetes-specific (Audit of Diabetes-Dependent Quality of Life) instruments. The severity of diabetes complications was measured using an adapted Diabetes Complication Score Index (DCSI) ranging from 0 to 14. We used multiple imputations to deal with missing data.

resultsWe included 1892 adults, 48% women, with a median (interquartile range [IQR]) age of 38 (28; 51) years. The mean overall EQ-5D-5L HRQoL score was 71.1 ± 17.7 (maximum 100), with the following number of participants negatively impacted for each domain: 271 (14%) for mobility, 94 (5%) for self-care, 378 (19%) for usual activities, 853 (45%) for pain/discomfort and 983 (52%) for anxiety/depression. The median (IQR) DCSI was 1 (0; 2). In multivariable models, a one-step increase in DCSI was associated with a 1.5% decrease in overall EQ-5D-5L HRQoL. DCSI was also inversely associated with all domains of the generic scale except anxiety/depression and 17 domains of the diabetes-specific scale.

conclusionsWe observed an inverse association between the severity of complications and overall HRQoL and most of its dimensions. Our results highlight the need to reinforce the prevention of complications to improve the overall well-being of people with T1D.

Indexed as

Diabetes ComplicationsDiabetes Mellitus, Type 1Quality of LifeAdultCross-Sectional StudiesFemaleFranceHumansLongitudinal StudiesMaleMiddle AgedSeverity of Illness IndexSurveys and QuestionnairesADDQoLDCSIdiabetes‐related complicationsEQ‐5D‐5Lhealth‐related quality of lifetype 1 diabetes

Identifiers

PMID41328549
PMCPMC12803608

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.